Healthy Skepticism Library item: 9093
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
PehrOlov P.
[Novartis should discontinue its patent case in India!]
Lakartidningen 2007 Feb 14; 104:(7):524
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17375688&query_hl=1&itool=pubmed_DocSum
Abstract:
No abstract available.
Keywords:
Publication Types:
Letter
MeSH Terms:
Antineoplastic Agents*/economics
Drug Industry/economics
Drug Industry/legislation & jurisprudence*
Humans
India
Patents/legislation & jurisprudence*
Piperazines*/economics
Pyrimidines*/economics
Substances:
Antineoplastic Agents
Piperazines
Pyrimidines
imatinib
Notes:
Swedish.
